| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 180.79B | 180.10B | 178.78B | 170.77B | 163.31B | 147.88B |
| Gross Profit | 41.08B | 42.05B | 40.08B | 29.69B | 26.14B | 27.00B |
| EBITDA | 20.61B | 19.32B | 20.37B | 11.03B | 7.68B | 10.00B |
| Net Income | 6.08B | 3.96B | 6.29B | 8.45B | 7.91B | 3.66B |
Balance Sheet | ||||||
| Total Assets | 192.18B | 181.96B | 202.20B | 191.43B | 196.12B | 189.50B |
| Cash, Cash Equivalents and Short-Term Investments | 36.72B | 28.91B | 40.60B | 25.07B | 28.00B | 31.48B |
| Total Debt | 45.43B | 37.56B | 48.62B | 44.73B | 48.00B | 30.03B |
| Total Liabilities | 76.94B | 67.36B | 82.85B | 74.08B | 83.54B | 79.57B |
| Stockholders Equity | 110.72B | 112.01B | 114.61B | 112.17B | 107.18B | 101.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.72B | 18.71B | 5.38B | -11.50B | -3.92B |
| Operating Cash Flow | 0.00 | 12.34B | 22.59B | 12.74B | 6.23B | 6.36B |
| Investing Cash Flow | 0.00 | -5.31B | -5.63B | -6.67B | -21.56B | 344.00M |
| Financing Cash Flow | 0.00 | -19.16B | -1.69B | -8.99B | 11.65B | 6.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥50.36B | 9.98 | ― | 2.12% | 6.02% | 101.02% | |
73 Outperform | ¥69.31B | 7.81 | ― | 1.55% | 6.02% | 5.87% | |
71 Outperform | ¥12.22B | 6.44 | ― | 1.91% | 1.42% | 29.11% | |
69 Neutral | ¥31.64B | 10.29 | ― | 2.84% | 1.00% | 15.35% | |
65 Neutral | ¥208.38B | 12.79 | 13.33% | 3.47% | 3.37% | 5.12% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥102.70B | -8.07 | ― | 3.97% | 0.74% | -35.11% |